Adverse Drug Experience Communications and Reporting Industry Perspective: Regulations and Practice
Adverse drug experience (ADE) reporting and communications are a critical responsibility of the pharmaceutical industry. This process can directly affect health care, but it has important regulatory implications. This paper briefly describes the regulatory responsibilities of the industry, how the r...
Gespeichert in:
Veröffentlicht in: | Drug information journal 1991-01, Vol.25 (1), p.131-137 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!